In structure-based drug design, the three-dimensional structure of a drug target interacting with small molecules is used to guide drug discovery. "Structure-based drug design represents the idea that you can see exactly how your molecule interacts with its target protein.”This structural information can be obtained with X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR). Originally, structure-based drug design was equated with de novo design or building a molecule from the ground up. Structure-based drug design relies on knowledge of the three dimensional structure of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create a homology model of the target based on the experimental structure of a related protein. As experimental methods such as X-ray crystallography and NMR develop, the amount of information concerning 3D structures of biomolecular targets has increased dramatically. Current methods for structure-based drug design can be divided roughly into two categories : Ligand-based drug design & receptor-based drug design.
"synopsis" may belong to another edition of this title.
I am pursuing M.Tech Biotech from GBU,India.My area of interests are CAAD,Microarray Analysis etc.I had done various projects which got accepted at National / International level & got two publications in Journal of Computational Intelligence in Bioinformatics.I am also working as RA at BCS-Insilico Biology,Lucknow & imparting training to students.
"About this title" may belong to another edition of this title.
Shipping:
US$ 33.18
From United Kingdom to U.S.A.
Shipping:
US$ 26.11
From Germany to U.S.A.
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In structure-based drug design, the three-dimensional structure of a drug target interacting with small molecules is used to guide drug discovery. 'Structure-based drug design represents the idea that you can see exactly how your molecule interacts with its target protein. This structural information can be obtained with X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR). Originally, structure-based drug design was equated with de novo design or building a molecule from the ground up. Structure-based drug design relies on knowledge of the three dimensional structure of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create a homology model of the target based on the experimental structure of a related protein. As experimental methods such as X-ray crystallography and NMR develop, the amount of information concerning 3D structures of biomolecular targets has increased dramatically. Current methods for structure-based drug design can be divided roughly into two categories : Ligand-based drug design & receptor-based drug design. 56 pp. Englisch. Seller Inventory # 9783846584859
Quantity: 2 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In structure-based drug design, the three-dimensional structure of a drug target interacting with small molecules is used to guide drug discovery. 'Structure-based drug design represents the idea that you can see exactly how your molecule interacts with its target protein. This structural information can be obtained with X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR). Originally, structure-based drug design was equated with de novo design or building a molecule from the ground up. Structure-based drug design relies on knowledge of the three dimensional structure of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create a homology model of the target based on the experimental structure of a related protein. As experimental methods such as X-ray crystallography and NMR develop, the amount of information concerning 3D structures of biomolecular targets has increased dramatically. Current methods for structure-based drug design can be divided roughly into two categories : Ligand-based drug design & receptor-based drug design. Seller Inventory # 9783846584859
Quantity: 1 available
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Raj UtkarshI am pursuing M.Tech Biotech from GBU,India.My area of interests are CAAD,Microarray Analysis etc.I had done various projects which got accepted at National / International level & got two publications in Journal of Comput. Seller Inventory # 5501339
Quantity: Over 20 available
Seller: Mispah books, Redhill, SURRE, United Kingdom
Paperback. Condition: Like New. Like New. book. Seller Inventory # ERICA75838465848515
Quantity: 1 available